Granules India acquires auctus pharma bulk drugs manufacturer Rs 120 crore
X
Waste Management Expo 2020 MAR 12&13 BIEC, Bengaluru, India

Granules India acquires API manufacturer, Auctus Pharma

10:19 AM, 6th November 2013
Granules India acquires Auctus Pharma

HYDERABAD, INDIA: Indian pharmaceutical major, Granules India has acquired the unlisted Hyderabad-based Auctus Pharma, a manufacturer of bulk drugs or active pharmaceutical ingredients (APIs) for Rs 120 crore ($19.30 million).

Auctus’s product portfolio includes 12 APIs as well as key intermediates of those APIs. The APIs are in several therapeutic categories such as antihistaminic, antihypertensive, antithrombotic and anticonvulsant and more. Auctus’s APIs and intermediates sell in 50 countries. The team and assets from the acquisition will initially operate as a separate division with Granules. Granules also announced the opening of a new research and development (R&D) facility in Hyderabad. This will focus on full scale generic API development and supplement the company’s existing R&D facility in Pune which focuses on sustainable technology development.

“Auctus provides Granules with a meaningful API platform which has a US FDA approved site to strengthen our finished dosage division. Granules will offer tremendous value to customers since we can provide supply security all the way from key intermediates to finished dosages for these products. We will be a market leader by implementing our operational excellence philosophy while leveraging Auctus’ regulatory approvals. In order to accelerate growth with a sustainable development engine, we have established a new R&D facility to enable finished dosage filings for our new APIs,” said C Krishna Prasad, Managing Director, Granules India.

© Worldofchemicals News 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Showa Denko, KH Neochem to dissolve ethyl acetate JV

TOKYO, JAPAN: Showa Denko (SDK) and KH Neochem Co Ltd (KHNC) have agreed to dissolve their joint venture, Japan Ethyl Acetate Co Ltd (JEA). The JV was ...

Read more
Foster Wheeler bags FEED contract for LNG project in Russia

ZUG, SWITZERLAND: Foster Wheeler’s subsidiary of Global Engineering and Construction Group has been selected by Rosneft and ExxonMobil to undert ...

Read more
PhosAgro begins construction of ammonia plant in Russia

MOSCOW, RUSSIA: PhosAgro, one of the world’s leading vertically integrated phosphate-based fertilizer producers, has begun construction of a new ...

Read more
Solvay completes the acquisition of Chemlogics

BRUSSELS, BELGIUM: Solvay closed the acquisition of privately-held Chemlogics, following clearance from the relevant anti-trust authorities. This acqu ...

Read more
Airgas acquires Encompass Gas Group

RADNOR, US: Airgas Inc, leading suppliers of industrial, medical, and specialty gases and related products, has completed the acquisition of the asset ...

Read more
Scientists explore the benefits of defects in diamond

CALIFORNIA, US: From supersensitive detections of magnetic fields to quantum information processing, the key to a number of highly promising advanced ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X